Targeting Metastatic Breast Cancers by Alkaline Glucosodiene Molecules Via a Metabolic Pathway Phase I Clinical Trial

Clinical trial NCT05957939 · UNKNOWN

Trial details

NCT number: NCT05957939
Sponsor: Ministry of Health, Saudi Arabia
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

TNBC - Triple-Negative Breast Cancer

Start date: 2024-01-01
Primary completion: 2024-12-31
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.